AMRI : Summary for Albany Molecular Research, Inc. - Yahoo Finance

U.S. Markets closed

Albany Molecular Research, Inc. (AMRI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.61-0.06 (-0.32%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close18.67
Bid0.00 x
Ask0.00 x
Day's Range18.55 - 18.83
52 Week Range12.45 - 19.35
Avg. Volume218,352
Market Cap773.82M
PE Ratio (TTM)-12.74
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire6 days ago

    AMRI Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call

    ALBANY, N.Y., Feb. 15, 2017 /PRNewswire/ -- AMRI (AMRI) today announced it will issue fourth quarter and full year 2016 financial results before the opening of the market on Tuesday, February 21, 2017.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call can be accessed by dialing (866) 208-5728 (domestic calls) or (224) 633-1279 (international calls) at 8:20 a.m. ET and entering passcode 61743127. A replay of the conference call can be accessed for 24 hours at (855) 859-2056 (domestic calls) or (404) 537-3406 (international calls) and entering passcode 61743127.

  • PR Newswire14 days ago

    AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery

    ALBANY, N.Y., Feb. 7, 2017 /PRNewswire/ -- AMRI (AMRI), a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes Biosolutions to develop new applications for using high throughput mass spectrometry (MS) for drug discovery. AMRI has acquired the new MALDI PharmaPulse system from Bruker Daltonics and HighRes Biosolutions.  The system will be deployed at AMRI's Integrated Drug Discovery Center and, in accordance with the terms of the alliance, Bruker Daltonics and HighRes Biosolutions will provide training and consulting to AMRI biologists to aid them in their development of protocols on the system that can be used for high throughput screening drug discovery programs.

  • Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : January 20, 2017
    Capital Cubelast month

    Albany Molecular Research, Inc. – Value Analysis (NASDAQ:AMRI) : January 20, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Albany Molecular Research, Inc. a score of 28. Our analysis is based on comparing Albany Molecular Research, Inc. with the following peers – Charles River Laboratories International, Inc., Elite Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., Cambrex Corporation, Aceto Corporation, General Electric Company, Sanofi Sponsored ADR, Ligand Pharmaceuticals Incorporated ... Read more (Read more...)